Coverage
-
August 02, 2012
A New Jersey federal judge on Thursday said she was inclined to stay Hoffman-La Roche Inc.'s patent infringement action against Teva Pharmaceuticals USA Inc. over chemotherapy drug Xeloda based on the dismissal of an earlier case and its pending appeal.
1 other articles on this case.
View all »